• No results found

off-label

Off-label Utilization of Antidepressants

Off-label Utilization of Antidepressants

... studies, off-label utilization naturally often lacks the validation by large scientific databases, and is at its best based on expert ...receiving off-label antidepressant ...an ...

6

Off-Label Use of Recombinant Factor VIIa in Pediatric Patients

Off-Label Use of Recombinant Factor VIIa in Pediatric Patients

... RESULTS: Three hundred and eighty-eight pediatric patients received off-label rFVIIa from 2003 to 2009. Median age was 12 months (interquartile range 1 month to 11 years). Clinical context included cardiac ...

10

After Caronia: First Amendment Concerns in Off-Label Promotion

After Caronia: First Amendment Concerns in Off-Label Promotion

... of off-label promotion to take the legal analysis outside of the scope of the First ...on off-label promotion are not subject to the heightened scrutiny standard the Court employed in IMS ...

65

Uses of Drugs Not Described in the Package Insert (Off-Label Uses)

Uses of Drugs Not Described in the Package Insert (Off-Label Uses)

... approved label means that the evidence required by law to allow their inclusion in the label has not been submitted to the Food and Drug Administration ...product label. Off-label use ...

5

ASSESSMENT OF OFF LABEL DRUG USE IN A TERTIARY CARE HOSPITAL

ASSESSMENT OF OFF LABEL DRUG USE IN A TERTIARY CARE HOSPITAL

... prescribed off-label ...prescribed off-label ...used off- label drug 25, 26, 38 ...used off-label drugs 28 ...used off-label drugs 28 . The commonly ...

8

Off-label drugs use in pediatric palliative care

Off-label drugs use in pediatric palliative care

... drug off-label means prescribing it in conditions that differ from those for which it has been authorized, in terms of age, dosage regimen (dose or frequency of administration), therapeutic indication, ...

6

Off Label Use of Drug in Pediatrics: A Systematic Review

Off Label Use of Drug in Pediatrics: A Systematic Review

... prescription off label, the health professional must reconcile clinical experience from careful clinical observations and external ...of off-label use and unlicesed of drugs in our midst, ...

5

Off Label Use of Drugs and Devices in the Neuroendovascular Suite

Off Label Use of Drugs and Devices in the Neuroendovascular Suite

... Off-Label Use. Intraprocedural thrombosis and ischemic events following endovascular procedures (category III). The experience of using platelet glycoprotein IIb/IIIa inhibitors abciximab (Reo- pro; Johnson ...

10

OFF LABEL USE OF ANTIBACTERIALS IN A CONTEXT OF ANTIMICROBIAL RESISTANCE THREAT

OFF LABEL USE OF ANTIBACTERIALS IN A CONTEXT OF ANTIMICROBIAL RESISTANCE THREAT

... the off-label use and the selected independent variables was performed through univariate and multivariate analyses using the binary logistic regression ...on off-label use was verified in the ...

6

A Survey of the Use of Off-Label and Unlicensed Drugs in a Dutch Children’s Hospital

A Survey of the Use of Off-Label and Unlicensed Drugs in a Dutch Children’s Hospital

... that off-label or unli- censed use of a drug may not be an inappropriate use (because of reasonable research based foundations of prescription protocol), but may be judged as such when the legal liability ...

7

Off-label use of orphan medicinal products: a Belgian qualitative study

Off-label use of orphan medicinal products: a Belgian qualitative study

... with off-label use; clinical evidence demonstrating quality, safety and effi- cacy is often lacking and no risk-analysis by regulatory agencies is carried out [2, ...such, off- label use of ...

9

In-/off-label use of biologic therapy in systemic lupus erythematosus

In-/off-label use of biologic therapy in systemic lupus erythematosus

... In recent times, hope was raised in systemic lupus ery- thematosus (SLE) for biologic therapies that are capable of specific molecular targeting at distinct key points. Novel therapies tested in SLE comprise ...

6

Aneurysmal bone cyst: results of an off label treatment with Denosumab

Aneurysmal bone cyst: results of an off label treatment with Denosumab

... Retrospectively all 65 patients with ABCs treated at our institution between 1982 and 2014 were analyzed with data having been collected in a prospective fashion. In 6 cases, Denosumab was used off-label in ...

6

Prevalence and factors associated with off-label antidepressant prescriptions for insomnia

Prevalence and factors associated with off-label antidepressant prescriptions for insomnia

... between off-label antidepressants and FDA-approved hyp- notics using weight-adjusted Chi-squared ...of off-label antidepressant use associ- ated with patient and physician socioeconomic ...

10

The major role of clinicians in the discovery of off label drug therapies

The major role of clinicians in the discovery of off label drug therapies

... The importance of clinicians as innovators has not been explored in pharmacotherapy to our knowledge. Yet, as we will show, they are responsible for discovering over half of off-label applications for ...

20

Off-Label Uses of Drugs in Children

Off-Label Uses of Drugs in Children

... undertake off-label prescrib- ing, the clinician must assess what level of risk is acceptable and appropriate for given patient, recog- nizing that all the risk cannot be defined in ...

7

Off-label drugs for weight management

Off-label drugs for weight management

... FDA label, and is intended to review some of the data on how US physicians are actually using drugs ...FDA label (Ohio Admin- istrative Code ...presume off-label use of controlled substance ...

12

OFF LABEL USE OF MEDICINES IN CHILDREN

OFF LABEL USE OF MEDICINES IN CHILDREN

... Clinical decision making should always be guided by the best available evidence and the well-being of the individual patient. Clinicians use their professional knowledge and judgment to determine drug utilization in ...

9

Off-Label Use of Drugs in Children

Off-Label Use of Drugs in Children

... However, off-label drug use remains an important public health issue for infants, children, and adolescents, because an over- whelming number of drugs still have no information in the labeling for use in ...

7

Off-Label Prescribing in Pediatric Outpatients

Off-Label Prescribing in Pediatric Outpatients

... horizontal measures, to ensure that medicinal products are researched, developed and authorised to meet the therapeutic needs of children. ” This regulation focuses on both public actors (European member states), ...

12

Show all 9864 documents...

Related subjects